2007 Fiscal Year Final Research Report Summary
The role of innate immunity in choroidal neovascularization
Project/Area Number |
18390469
|
Research Category |
Grant-in-Aid for Scientific Research (B)
|
Allocation Type | Single-year Grants |
Section | 一般 |
Research Field |
Ophthalmology
|
Research Institution | Kyushu University |
Principal Investigator |
SONODA Koh-hei Kyushu University, Graduate School of Medical Science, Assistant Professor (10294943)
|
Co-Investigator(Kenkyū-buntansha) |
YOSHIDA Hiroki Saga University, Faculty of Medicine, Professor (40260715)
EGASHIRA Kensuke KYUSHU UNIVERSITY, Graduate School of Medical Science, Associate Professor (60260379)
YONEMITSU Yoshikazu Chiba University, Graduate School of Medical Science, Professor (40315065)
HATA Yasuaki KYUSHU UNIVERSITY, Graduate School of Medical Science, Associate Professor (90346776)
ISHIBASHI Tatsuro KYUSHU UNIVERSITY, Graduate School of Medical Science, Professor (30150428)
|
Project Period (FY) |
2006 – 2007
|
Keywords | corneal transplantation / NKT cells / cytokine / tolerance / DNA chip / gene transfer / immune therapy |
Research Abstract |
1: The establishment of subretinal scaring model in mice. Methods Under the microscope, we inoculated peritoneal exudate cells (PECs). PECs were obtained from peritoneal washes of either B6 mice, three days after they were inoculated intraperitoneally (i.p.) with 2.5ml of an aged solution of 3% thioglycollate. Seven days later, the subretinal scaring was observed. Evaluation We stained scaring parts by Glia1 Fibriary Acidic Protein (GFAP), the marker of glia1 cells. Then we measure the area and valuate scaring. 2: Identification of local accumulating cells and the screening of cytokine and chemokines produced by these cells. Inflammatory macrophages and transformed retinal pigment epithelium (RPE). We screened specific cytokines and chemokines by RNAse protection assay and multiplex protein beads assay. We found both macrophages and RPE predominantly produced IL-6 and MCP-1. 3: The suppression of subretinal scaring by blocking of IL-6. Systemic treatment of IL-6 blocking antibody reduced the size of scaring. Also we inoculated IL-10-trsformed RPEs into the vitreous cavity for therapeutic purpose, and confirmed the reduction of scaring.
|
-
-
-
-
[Presentation] 眼炎症と自然免疫2007
Author(s)
園田 康平
Organizer
第111回日本眼科学会総会
Place of Presentation
大阪国際会議場
Year and Date
2007-04-21
Description
「研究成果報告書概要(和文)」より